Coronavirus Good News
  • Home
  • Good News
  • Home
  • Good News

JUST POSITIVE GOOD NEWS ABOUT COVID-19

There is so much negativity in the news about COVID-19, we want to give you all the positive good news that is happening with research, clinical trials, improvements and anything that we can be positive about that you may not have seen.

IF YOU JUST WANT FEEL GOOD, INSPIRING STORIES AND VIDEOS THEN LOOK AT OUR NEW PAGE HERE

Moderna says it’s preparing global launch of Covid vaccine as it takes in $1.1 billion in deposits

10/29/2020

 
Moderna is prepping for the global launch of its potential coronavirus vaccine, already taking in $1.1 billion in deposits from governments awaiting the potentially lifesaving drug, the biotech firm said Thursday in its third-quarter earnings report.

The Cambridge, Massachusetts-based company said it was in ongoing talks with the World Health Organization-backed COVAX initiative on a tiered pricing proposal for its potential vaccine, which it’s tentatively calling mRNA-1273. It already has supply agreements in North America, the Middle East and in other regions of the world.

“We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around the world,” Moderna CEO Stephane Bancel said in a press release. “Moderna is committed to the highest data quality standards and rigorous scientific research as we continue to work with regulators to advance mRNA-1273.”

Moderna, a frontrunner in the Covid-19 vaccine race, said last week it had completed enrollment for its 30,000 participants late-stage trial. As of last week, more than 25,650 participants had received the second of the company’s two-dose Covid-19 vaccine. The company said about 37% of the participants were from diverse communities and 42% were at high risk of severe disease.

Just over half, 53%, of the participants in the trial are male and 47% are female, according to a presentation from the company. The vast majority of participants are over the age of 25, with only 5% in the 18 to 24 age group.

On a call with investors Thursday, Bancel said the company expects the data and safety monitoring board, which will assess whether the trial is successful, will conduct its first interim analysis in November. The board will not conduct its analysis until after there are 53 cases of Covid-19 diagnosed in Moderna’s phase three trial.

https://www.cnbc.com/2020/10/29/coronavirus-moderna-says-it-is-actively-preparing-for-launch-of-vaccine.html

HELP US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you've enjoyed the site we'd love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.

ENJOY FEEL GOOD, INSPIRING STORIES AND VIDEOS ?

Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.

Comments are closed.

    Who Am I ?

    Just someone trying to highlight the positive news amongst a sea of negativity.


    Archives

    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020

    Categories

    All
    Australia
    Austria
    Brazil
    Canada
    China
    Clinical Trials
    Companies
    Denmark
    Education
    France
    Germany
    Greece
    India
    Ireland
    Italy
    Lockdown
    Netherlands
    New Zealand
    Portugal
    PPE
    Reopen
    South Korea
    Spain
    Statistics
    Summary
    Switzerland
    Testing
    Treatment
    Turkey
    UK
    USA
    Vaccine
    Ventilators

    RSS Feed

Proudly powered by Weebly